Hansa Biopharma AB Share Price London S.E.
Equities
0RC7
SE0002148817
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.56 SEK | +2.88% | +15.72% | +58.85% |
21/05 | Hansa Biopharma to Present Data At 2024 American Transplant Congress Annual Meeting | CI |
18/04 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 |
Sales 2024 * | 239M 22.62M 1.88B | Sales 2025 * | 343M 32.41M 2.69B | Capitalization | 2.66B 251M 20.9B |
---|---|---|---|---|---|
Net income 2024 * | -735M -69.51M -5.78B | Net income 2025 * | -712M -67.34M -5.6B | EV / Sales 2024 * | 13.1 x |
Net Debt 2024 * | 474M 44.83M 3.73B | Net Debt 2025 * | 733M 69.36M 5.77B | EV / Sales 2025 * | 9.9 x |
P/E ratio 2024 * |
-3.46
x | P/E ratio 2025 * |
-4.11
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.64% |
Latest transcript on Hansa Biopharma AB
1 day | +2.73% | ||
1 week | +15.72% | ||
Current month | +48.60% | ||
1 month | +58.09% | ||
3 months | +30.23% | ||
6 months | +64.20% | ||
Current year | +58.85% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Tulstrup
CEO | Chief Executive Officer | 59 | 20/18/20 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/12 |
Achim Kaufhold
CTO | Chief Tech/Sci/R&D Officer | 66 | 29/20/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 29/18/29 | |
Peter Nicklin
CHM | Chairman | 61 | 30/22/30 |
Mats Blom
BRD | Director/Board Member | 59 | 22/19/22 |
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 42.56 | +2.88% | 0 |
27/24/27 | 40.25 | -2.71% | 2,493 |
24/24/24 | 41.37 | -4.19% | 7,792 |
23/24/23 | 43.18 | +7.20% | 2,181 |
22/24/22 | 40.28 | +2.59% | 1,949 |
Delayed Quote London S.E., May 28, 2024 at 08:55 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- HNSA Stock
- 0RC7 Stock